These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 6560767)

  • 1. RN special report on over-the-counter products. Nurses' unparalelled impact on the use of OTC products.
    RN; 1983 Sep; 46(9):69-70. PubMed ID: 6560767
    [No Abstract]   [Full Text] [Related]  

  • 2. RN special report on over-the-counter products. A fresh look at OTC drug interactions: effects you can't afford to overlook.
    RN; 1983 Sep; 46(9):77-89. PubMed ID: 6560769
    [No Abstract]   [Full Text] [Related]  

  • 3. RN special report on over-the-counter products. The changing nature of OTCs: why - and how - to keep up to date.
    Gossel TA
    RN; 1983 Sep; 46(9):73-5. PubMed ID: 6560768
    [No Abstract]   [Full Text] [Related]  

  • 4. Abuse of proprietary (over-the-counter) drugs.
    Williams JF; Kokotailo PK
    Adolesc Med Clin; 2006 Oct; 17(3):733-50; abstract xiii. PubMed ID: 17030289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Over-the-counter medications and self-care.
    Lowe NK; Ryan-Wenger NM
    Nurse Pract; 1999 Dec; 24(12):34-44. PubMed ID: 10635517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of over-the-counter drug-related overdoses at Accident and Emergency departments in Northern Ireland--a retrospective evaluation.
    Wazaify M; Kennedy S; Hughes CM; McElnay JC
    J Clin Pharm Ther; 2005 Feb; 30(1):39-44. PubMed ID: 15659002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are instructions for over-the-counter nicotine replacement therapy products readable?
    Stevens AB; McDaniel KS; Glover ED; Wallace LS
    Am J Health Behav; 2007; 31 Suppl 1():S79-84. PubMed ID: 17931140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promotion of OTC products within a network-model HMO.
    Gilderman A; Shinmoto M; Andrews S
    Med Interface; 1996 Jun; 9(6):104-8. PubMed ID: 10157923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OTC survival guide. 20 questions. Do you how to safely get the greatest benefit from over-the-counter (OTC) drugs and products? Answer these 20 questions and find out!
    Roberts SS
    Diabetes Forecast; 2004 Feb; 57(2):57-8, 60-1. PubMed ID: 14976937
    [No Abstract]   [Full Text] [Related]  

  • 10. Cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the-counter human use; amendment of monograph for OTC nasal decongestant drug products. Final rule.
    Fed Regist; 2006 Aug; 71(147):83358[sic., should be 43358]-63. PubMed ID: 16892519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the-counter human use; final rule for over-the-counter antitussive drug products; technical amendment. Final rule, technical amendment.
    Food and Drug Administration, HHS
    Fed Regist; 2007 Nov; 72(230):67639-40. PubMed ID: 18064767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the-counter human use; amendment of final monograph for over-the-counter nasal decongestant drug products. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2005 Oct; 70(195):58974-7. PubMed ID: 16217879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDA launches campaign on OTC pain relief products.
    FDA Consum; 2004; 38(2):8. PubMed ID: 15101357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ophthalmic drug products for over-the-counter human use; final monograph; technical amendment. Final rule; technical amendment.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Feb; 68(33):7919-21. PubMed ID: 12593411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usage of antifungal drugs for therapy of genital Candida infections, purchased as over-the-counter products or by prescription: 2. Factors that may have influenced the marked changes in sales volumes during the 1990s.
    Mårdh PA; Wågström J; Landgren M; Holmén J
    Infect Dis Obstet Gynecol; 2004 Jun; 12(2):99-108. PubMed ID: 15739824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Over-the-counter drug use by medicare beneficiaries in nursing homes: implications for practice and policy.
    Simoni-Wastila L; Stuart BC; Shaffer T
    J Am Geriatr Soc; 2006 Oct; 54(10):1543-9. PubMed ID: 17038072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anorectal drug products for over-the-counter human use. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Aug; 68(165):51167-70. PubMed ID: 12952012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Over-the-counter human drugs; labeling requirements. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 1999 Mar; 64(51):13254-303. PubMed ID: 10557606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of use and public perception of over-the-counter pain relievers: focus on nonsteroidal antiinflammatory drugs.
    Wilcox CM; Cryer B; Triadafilopoulos G
    J Rheumatol; 2005 Nov; 32(11):2218-24. PubMed ID: 16265706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tamper-evident packaging requirements for over-the-counter human drug products--FDA. Final rule.
    Fed Regist; 1998 Nov; 63(213):59463-71. PubMed ID: 10187120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.